Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome
Condition:   Endogenous Cushing's Syndrome Intervention:   Drug: Osilodrostat Sponsor:   RECORDATI GROUP Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 19, 2022 Category: Research Source Type: clinical trials

SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome
Conditions:   Cushing's Syndrome I;   Cushing Disease Due to Increased ACTH Secretion;   Cortisol Excess;   Cortisol; Hypersecretion;   Cortisol Overproduction;   Ectopic ACTH Secretion Interventions:   Drug: SPI-62;   Drug: Placebo Sponsor:   Sparrow Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2022 Category: Research Source Type: clinical trials